Dashboard
Dividend Tracker
My Portfolio
Portfolios
Investors
Analysts
Community
Calendars
Economic Calendar
Dividend Calendar
Earnings Calendar
Splits Calendar
IPO Calendar
Markets
Stocks
Indices
Forex
Crypto
Commodities
News
Sign Up
Sign In
Your search results will appear here.
Light Mode
Dark Mode
Sign Up
Sign In
Elevance Health, Inc. (ELV)
Market Closed
17 Jul, 20:00
NYSE
All
(12)
DE
(5)
AT
(1)
MX
(1)
IT
(2)
GB
(1)
RO
(1)
US
(1)
NYSE
Primary
LSE
XMIL
XSTU
XDUS
XETRA
XMUN
XFRA
XMEX
XWBO
REGS
XMIL
$
373.
11
+0.26
+0.0697%
$
90.39B
Market Cap
18.21
P/E Ratio
6.88%
Div Yield
1.92M
Volume
33.06
Eps
$
372.85
Previous Close
Investors:
TJD
LC
CE
+366
Watching
Watch
Add Transaction
Day Range
365.38
377.76
Year Range
273.71
436.24
Want to track
ELV
and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Get Started For Free
Overview
Dividends
Earnings
Splits
Statistics
News
Historical Data
Investors
Elevance Health, Inc. (ELV) Statistics
Valuation metrics
Market Cap
90.39B
Enterprise value
101.73B
Trailing P/E (ttm)
16.58
Forward P/E
13.49
PEG ratio
-3.69
Price/Sales (ttm)
0.4
Price/Book (mrq)
1.81
Enterprise Value/Revenue
0.51
Enterprise Value/EBITDA
12.7
Overview
Shares outstanding
217.37M
Float
216.71M
Shares short
5.16M
% Held by insiders
0%
% Held by institutions
0.94%
Average volume (10 days)
2.03M
Average volume (90 days)
1.84M
Price summary
52-Week low
273.71
52-Week high
436.24
Beta
0.67
50-Day moving average
402.91
200-Day moving average
348.11
Dividends and splits
Forward annual dividend rate
6.88
Forward annual dividend yield
0.0174%
Trailing annual dividend rate
6.86
Trailing annual dividend yield
0.0184%
5-Year annual dividend yield
1.34%
Payout ratio
0.3
Dividend Date
25 Jun 2026
Ex-Dividend Date
10 Jun 2026
Last split factor
2:1
Last split Date
1 Jun 2005
Financials
Fiscal year
Fiscal year ends
31 Dec 2025
Most recent quarter (mrq)
31 Mar 2026
Profitability
Profit margin
0.02%
Operating margin
0.04%
Operational effectiveness
Return on assets
0.04%
Return on equity
0.11%
Income Statement
Revenue (ttm)
200.42B
Revenue per share (ttm)
922.96
Quarterly revenue growth (yoy)
0.03%
Gross profit (ttm)
51.89B
EBITDA
8.54B
Net income to common (ttm)
5.24B
Diluted EPS (ttm)
22.78
Quarterly earnings growth (yoy)
-0.19%
Balance Sheet
Total cash (mrq)
37.07B
Total cash per share (mrq)
172.16
Total debt (mrq)
31.84B
Total Debt/Equity (mrq)
0.69
Current ratio (mrq)
1.52%
Book value per share (mrq)
206.62
Cash Flow
Cash flow statement
7.61B
Levered free cash flow (LFCF)
4.3B